The Hirshberg Foundation is excited to have the esteemed Dr. Saluja at our 15th Annual Symposium on Pancreatic Cancer to speak on new drug therapies that target pancreatic cancer.
Ashok K. Saluja, PhD is the Professor and Vice-Chair, Department of Surgery and Director, Sylvester Pancreatic Cancer Research Institute.
Dr. Saluja received his PhD in Biochemistry from Washington State University and did his postdoctoral training at Cornell University. Before joining the University of Minnesota in 2006, he was professor and director of the Pancreatic Diseases Center at UMass Medical School and, before that, at Harvard Medical School for twenty years.
Dr. Saluja’s research is primarily focused on pancreatic diseases and how it can be taken from bench to bedside. The Saluja Laboratory is interested in the role played by heat shock proteins in the pathophysiology of this resistance. The Lab has demonstrated that HSP70 is overexpressed in pancreatic cancer cells and that its inhibition leads to apoptotic cell death.
Dr. Saluja will speak about New Drug Therapies For Pancreatic Cancer.
To learn more about Ashok K. Saluja, Ph.D please visit
http://bm.med.miami.edu/faculty/facultybmb/ashok-k.-saluja-phd
